Fundamental dimension Equity attribute | BIOALeader $5.10▼-7.78% Cap $192.0MP/E -2.1x QuantScore56/100 | ACBPeer $3.88▼-2.27% Cap $245.6MP/E -2.8x QuantScore37/100 | ALLOPeer $1.250.00% Cap $431.9MP/E -1.9x QuantScore42/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
44/100 |
47/100 |
43/100 |
Valuation Multiples, PEG & DCF upside | 67/100 | 33/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 54/100 | 40/100 | 46/100 |
Growth Revenue / earnings growth & margins | 33/100 | 13/100 | 53/100 |
Sentiment Analyst ratings, targets & revisions | 80/100 | 50/100 | 69/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -2.1x | -2.8x | -1.9x |
Forward P/E (next FY) | -2.1x | -22.2x | -2.1x |
EV / EBITDA (TTM) | -1.3x | -3.7x | -3.0x |
Price / Sales | 18.5x | 1.2x | 93.1x |
Price / Free Cash Flow | -2.2x | -6.7x | -4.2x |
PEG ratio | 0.29 | 0.03 | -0.03 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 2 / 9 | 4 / 9 |
Altman Z-Score | 4.07 (Safe) | -11.58 (Distress) | -3.36 (Distress) |
Total debt / equity | 0.01 | 0.04 | 0.16 |
Quick ratio | 17.2x | 2.8x | 10.7x |
Interest coverage | -378.2x | -18.0x | -138.7x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | -6.6% | -100.0% |
Net income growth YoY | -13.4% | -7753.0% | +25.9% |
Gross margin (TTM) | 99.4% | 32.1% | 100.0% |
Operating margin (FY) | -1031.5% | -14.6% | — |
FCF margin (FY) | -915.5% | -11.2% | — |
5. Trailing price performancePrice change over period |
1M return | -27.7% | -5.4% | -25.1% |
3M return | -76.6% | +45.3% | -28.2% |
6M return | -70.1% | +14.5% | -45.9% |
Year to date | -61.5% | -8.1% | -8.8% |
1Y return | -33.2% | -23.8% | +4.2% |
3Y return | -72.1% | -8.9% | -55.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $8.84 +73.2% upside | $-18.71 -582.3% premium | $-0.1549 -112.4% premium |
Wall Street consensus target | $23.50 +360.8% · range $8.00–$40.00 | $5.92 +52.6% · range $1.00–$8.75 | $26.53 +2022.4% · range $3.85–$55.00 |
Consensus stance | 83% Buy17% Hold-0% Sell | 21% Buy57% Hold21% Sell | 63% Buy33% Hold3% Sell |